Education
About Us
Working with TipRanks
Follow Us
Bionexus Gene Lab Corporation (BGLC)
:BGLC
BGLC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.21 - $1.07
Previous Close$0.33
Volume739.27K
Average Volume (3M)156.26K
Market Cap
$5.88M
Enterprise ValueN/A
Total Cash (Recent Filing)$659.24K
Total Debt (Recent Filing)$62.94K
Price to Earnings (P/E)―
Beta1.64
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding17,967,663
10 Day Avg. Volume62,156
30 Day Avg. Volume156,263
Standard Deviation0.31
R-Squared0.06
Alpha-0.05
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.64
Price to Cash Flow (P/CF)-1.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
BioNexus Gene Lab Corp News
PremiumCompany Announcements
BioNexus Gene Lab Faces Delisting and Leadership Changes
PremiumCompany Announcements
BioNexus Receives Government Backing for Healthcare Tech
PremiumCompany Announcements
BioNexus Gene Lab’s Strategic Investment in AI Healthcare
PremiumCompany Announcements
BioNexus Gene Lab Expands Reach with Strategic InvestmentPremiumCompany Announcements
BioNexus Gene Lab Announces Major Board and Leadership Restructuring---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.13%
Mutual Funds
0.06% Other Institutional Investors
99.80% Public Companies and
Individual Investors
BGLC FAQ
What was Bionexus Gene Lab Corporation’s price range in the past 12 months?
Bionexus Gene Lab Corporation lowest stock price was $0.21 and its highest was $1.07 in the past 12 months.
What is Bionexus Gene Lab Corporation’s market cap?
Bionexus Gene Lab Corporation’s market cap is $5.88M.
When is Bionexus Gene Lab Corporation’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Bionexus Gene Lab Corporation’s earnings last quarter?
Currently, no data Available
Is Bionexus Gene Lab Corporation overvalued?
According to Wall Street analysts Bionexus Gene Lab Corporation’s price is currently Overvalued.
Does Bionexus Gene Lab Corporation pay dividends?
Bionexus Gene Lab Corporation does not currently pay dividends.
What is Bionexus Gene Lab Corporation’s EPS estimate?
Bionexus Gene Lab Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bionexus Gene Lab Corporation have?
Bionexus Gene Lab Corporation has 17,967,663 shares outstanding.
What happened to Bionexus Gene Lab Corporation’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Bionexus Gene Lab Corporation?
Currently, no hedge funds are holding shares in BGLC
---
Company Description
Bionexus Gene Lab Corporation
BioNexus Gene Lab Corp is an emerging molecular diagnostics company focused on the application of functional genomics to enable early diagnosis and personalized health management. It focuses on developing and marketing safe, effective, and non-invasive blood tests for the early detection of diseases. The company's non-invasive blood tests analyze changes in ribonucleic acid (or RNA) to detect the potentiality of 11 different diseases. These diseases include eight cancers (nasopharyngeal, lung, liver, stomach, breast, cervical, prostate, and colon), two bowel diseases (colitis and Crohn), and osteoarthritis.
---
Technical Analysis
---